|Red Rose Awards, Health & Care Business of the Year|
|Scrip Awards Winner|
|Queens Award for Enterprise|
MAC Clinical Research is a family of companies dedicated to improving global health. The organisation is working to develop new types of medicines through clinical trials.
Established in 1988, our healthcare suites operate right here on the Fylde Coast in Blackpool, and also in Yorkshire, Manchester and Staffordshire, so you can be sure that we have a clinic local to you.
Between Bispham and Poulton off Faraday Way – near the Norcross civil service offices - the Assessment Centre is in an inoffensive modern office building rather than a clinical hospital or clinic setting. There's also plenty of free parking.
Reception at the MAC Memory Assessment Centre
No matter how old you are, if you are concerned about your memory and worried that you might have a problem then you can simply phone and make an appointment for a memory test.
There are many reasons why people feel they have memory loss, including stressful jobs, alcohol, a cocktail of prescription drugs, or a traumatic event. If you’re worried that you might be one of the 800,000 people in the UK who have dementia, then it’s best to go along and get a check – which is completely free of charge and will put your mind at rest. Typically, dementia tends to affect older people, but the younger ones among us can be affected by early onset dementia and in fact there are 17,000 such people currently suffering from the condition in the UK today.
Some of the team at the MAC Memory Assessment Centre
Watch this short video about a patient's experience of being involved with the Memory Assessment Centre, and what a positive difference it's made.
You’ll be met by friendly staff and a cheery smile, before being met by one of the practitioners who might be a nurse, doctor or even a professor. In the consulting room the process will be explained to you, starting with a chat about your concerns and worries, and what has brought you there in the first place.
Watch this short video clip where you'll meet some of the people who you'll see if you visit MAC
Medication can be a factor in memory levels – things like painkillers for chronic pain, your former/current job is relevant, and patients are always encouraged to bring along a family member or friend to complete the picture.
Carrying out a memory assessment
There are different types of memory test depending on how a patient presents. A cognitive test is a measure of basic memory function, then a more challenging test probes further and is especially useful for people who have been former teachers and secretaries who always get good results even if they have memory impairment. The tests include simple recall of words and numbers, a little bit of written work like writing number digits out in full. None of it is designed to trip you up, and in fact the assessor will be observing you as a whole while they carry out the test, and using all the information which they observe in their verdict.
Well you’ve done exactly the right thing and been to exactly the right place. The service at MAC is free at the point of initial assessment, and if you are found to have a condition the service and any treatment which you receive is free while ever you need it.
You’ll be referred to your own GP and you may need to have simple blood tests to rule out things like thyroid problems and vitamin B12 deficiency which can cause similar symptoms and are easily treatable. Or you may need a CT scan to rule out strokes and vascular damage in your brain and confirm a diagnosis of Alzheimers. If you have got it, the recommendation will be made that you take Aricept (or a similar medication of this type) – the standard treatment for mild to moderate Alzheimers.
In fact the biggest majority of people (two thirds of them) with dementia live in the community while just one third live in a care home. Currently, only 43% of people with dementia in the UK receive a diagnosis, and as diagnosis and treatment improves so should the prognosis and quality of life. In 2012 the cost of dementia to the UK will be over £23 billion, so you can see why research and improvements in treatment and halting progression of the disease are vitally important. It doesn’t just affect each and every individual patient and their families, financially it affects all of us even if we just don’t know it.
The other benefit of the MAC Memory Assessment Centre is that they will keep an eye on you and keep checking your memory periodically for years to come if need be. Not only does it give you some peace of mind that you’re being monitored, it also creates a trail of evidence of your condition. And you’ve also got the benefit of an impartial advocate in the clinicians at the Centre, who will act on your best interests and on your behalf if they feel that your condition isn’t being managed as well as it could be, or if you would benefit from additional support or treatment. They’ll also signpost you to support services and other sources of help.
So far so good. What about the future and the progression of your disease? One of the benefits of being ‘on the books’ so to speak at MAC is that you can access clinical trials as they come on stream. Clinical trials are the bedrock of progress – without them we’d not have penicillin and the flu jab - on both of which millions depend every year. The MAC Memory Assessment Centre was formed by clinicians and the advancement of medicine and treatment is at the very heart of what they do, in fact they were part of the trials for Aricept which has fundamentally improved the lives of thousands of Alzheimers patients already.
If you do decide to take part in a trial, and the drug works for you, then you’ll be given the opportunity to continue taking it for the long term, as an add-on to the standard treatment with Aricept and whatever else you take. Now you can’t say fairer than that, it’s got to be a win-win situation for everyone.
Read more about the MAC Memory Assessment Centre, including a personal experience of the service.
The information contained in this page is supplied and maintained by the advertising business and is their sole responsibility E&OE.
Click the buttons below to show details for:
Around 8.5 million people in the UK are affected by joint pain from osteoarthritis. The pain and discomfort of this condition can be debilitating for many sufferers.
New research opportunities are available at MAC Clinical Research to evaluate potential new treatments for those suffering with osteoarthritis of the knee joint.
The study drug and assessments required by the study will be provided free of charge and you will be compensated £760 for your time and commitment.
The trial for Osteoarthritis is currently running at all of our clinics so you can pick one near to you - Blackpool, Barnsley, Cannock, Leeds, Liverpool, Manchester.
For more information, call 0800 6335507, text PAIN to 81025 or visit www.researchforyou.co.uk (And if you do get in touch please mention that you saw it here, thanks!)
Dementia Friends will be held at MAC Clinical Research, Blackpool, on the LAST FRIDAY of every month.
Dementia Friends gives people an understanding of dementia and the small things that people can do to make a difference - please join us.
Learn more about what it is like to live with dementia and turn that understanding into action.
Refreshments provided, free car parking on site. Phone 01253 444451 for more details and to register (and please say that you saw it here!)
Last Friday of every month from 2-3pm
Friday 24 February 2017
Friday 31 March 2017
Friday 28 April 2017
Every year thousands of people around the world take part in healthy research studies. Without healthy volunteers no new medications would be approved for use, and treatments which we all take for granted and expect to cure us of various conditions just wouldn't exist.
We're currently running clinical trials looking into potential treatments for osteoarthritis and dementia. We're also conducting a trial for healthy volunteers.
Want to find out more?
You can find out about trials for other treatments from our Facebook page too.
The Fylde Coast Dementia Hub will be a one-stop offering support and informatio
The new Fylde Coast Dementia Hub will be held every month in Blackpool. The Hub is a unique, community based service with open access for the Fylde Coast's residents with dementia, their families, friends and carers as well as people who may be worried about their memory.
The Hub will offer a large range of information and guidance which will be delivered in partnership with many organisations and individuals alike.
These services will include the memory clinic, dementia nurses, a range of support groups for both people with dementia and carers, dementia researchers, lawyers, financial advisers and benefits advisers to name but a few. Alzheimer's Society Dementia Advisers/Dementia Support Workers will also be on hand to offer advice and arrange home visits if required.
We will offer a beautiful venue where you can sit and have a cup of tea and a chat in a relaxed setting.
Fylde Coast Dementia Hub Dates for 2017
If you are affected by dementia or worried about your memory, come and find local information in one friendly place.
Thursday 16 February from 10am to 3pm at Clifton Hospital
Friday March 17 from 2-4pm at Trinity Hospice
Friday April 21 from 2-4pm at Trinity Hospice
Thursday May 18 from 10am to 3pm at Clifton Hospital
Friday 16 June from 2-4pm at Trinity Hospice
Friday July 21 from 2-4pm at Trinity Hospice
Thursday 24 August from 10am to 3pm at Clifton Hospital
Friday 15 September from 2-4pm at Trinity Hospice
Friday 20 October from 2-4pm at TRinity Hospice
Thursday November 16 from 10am to 3pm at Clifton Hospital
Friday December 15 from 2-4pm at Trinity Hospice
MAC are looking for men and women aged between 50 and 85 to join a Phase III study of a new add-on medication which may have the potential to improve the effects of current prescription medication.
There is a lack of treatment options available for people with Alzheimer’s. Current treatments only offer minor symptomatic improvements for a limited duration. No new drug treatments for Alzheimer’s have been approved in more than 10 yrs so there is an urgent need to trial new drugs.
MAC Clinical Research is currently running Phase III study looking at a new add-on medication that may have the potential to boost the positive effects of Donepezil (Aricept) in Alzheimer’s Disease.
To join this study you must have been diagnosed with mild Alzheimer’s disease and on a stable dose of donepezil.
Previous studies have demonstrated the new add-on drug was tolerated extremely well. Study tasks are simpler than other Alzheimer’s studies currently on trial.
Clinics are available here in Blackpool and also in Manchester, Staffordshire and Yorkshire if you've got friends and relatives in other parts of the country who would like to take part. Transport will be provided if required or reasonable travel expenses will be reimbursed
Key Inclusion Criteria*
-Participants must have a project partner, such as a spouse, close friend, or adult family member, who is also available to participate in the study by attending study visits and providing information about the participant’s thinking abilities and behaviour.
If you'd like to know more, get in touch with Nikki Armitstead the Senior Study Coordinator at MAC on 01253 444451. (Please mention that you saw it on this website, thanks!)
Without clinical research...
Without clinical research, there would be no new or improved medications.
By taking part in a clinical trial here at MAC, not only will you benefit from a comprehensive health check, but you will also gain a sense of pride knowing that you are helping to identify treatments that may benefit the lives of future generations.
Travel expenses will be reimbursed, and some trials also offer payment for your time and commitment.
To find out more, or to register to take part in a clinical trial here at MAC, call our friendly recruitment team on 0800 6335507 or visit researchforyou.co.uk. (Please mention that you saw it on this website, thanks!)
The number of people with dementia is steadily increasing. Currently there are about 850,000 cases in the UK, with numbers expected to reach over a million by 2021. The most common cause of dementia is Alzheimer’s disease. It begins when a protein called beta-amyloid forms senile plaques that start to clump together in the brain, damaging nerve cells and leading to memory loss and confusion.
David Allsop, Professor of Neuroscience, and Dr Mark Taylor, from the Faculty of Health and Medicine, have developed a new drug which in laboratory tests reduces the number of these senile plaques and the amount of brain inflammation and oxidative damage associated with Alzheimer’s disease.
Lancaster University has filed a patent application for the drug, and it will be progressing into clinical trials run by the north-west research company MAC Clinical Research. If it passes regulatory hurdles, the ultimate aim is to give the drug to people with mild symptoms of memory loss.
Professor Allsop said: “It is encouraging that our drug is being taken forward and will be tested on humans.
“Many people who are mildly forgetful may go on to develop the disease because senile plaques start forming years before any symptoms manifest themselves. The ultimate aim is to give the drug at that stage, to stop any more damage to the brain.”
Professor Allsop was the first scientist to isolate senile plaques from the human brain. Watch this little video clip about the project
Dr Steve Higham, Chief Operating Officer of MAC Clinical Research said: “Preventing Alzheimer's disease progression remains a critical unmet need for millions of people worldwide. With that in mind we are very pleased to begin this exciting partnership with Professor David Allsop, his team and Lancaster University.”
Dr James Pickett, Head of Research at Alzheimer’s Society which currently funds the research, said: “There’s a tremendous need for new treatments that can stop the development of dementia in its tracks. Trials in people are an essential step in the development of any new drug so it’s really positive to see this promising research being taken forward.
“Alzheimer’s Society will continue to fund drug development research like this to ensure the best new treatments reach the people who desperately need them as soon as possible.”
Other contributing researchers include groups led by Lancaster University’s Professor Christian Hölscher (formerly of Ulster University) and Professor Massimo Masserini at University of Milano-Bicocca, Italy.
Lancaster University launched the “Defying Dementia” campaign earlier this year, in order to raise awareness of Alzheimer’s and the new drug, and to raise funds for further research.
A spokesman for the campaign said "We still need your support to get the drug to the clinical trial stage. This includes assays to detect how much of the drug is in the body and also to perform a number of safety tests."
To donate, you can either visit our JustGiving page: www.justgiving.com/defyingdementia or visit our website for information on how to donate via post or over the phone: www.lancaster.ac.uki/defyingdementia Any size of donation is really appreciated and together we can defy dementia!
In terms of opportunities for businesses, we welcome sponsorship and support from everyone.
The service is free to access, you don’t need a referral, and any treatment which you may need will be free of charge too – either through the NHS or through MAC.
MAC Memory Assessment Centre at Blackpool
Don’t worry about memory loss, do something about it.
It will either put your mind at rest, or kick-start vital early treatment which will improve your quality of life no end by slowing progression of the disease.
You’ve got nothing to lose and everything to gain, so phone 01253 444451 today for more information.
Visit researchforyou.co.uk for more information about trials which might be starting in the future.
The defining symptoms of fibromyalgia are chronic widespread pain, fatigue, sleep disturbance, and heightened pain in response to tactile pressure (allodynia).
Thank you to everyone who has shown interest in the Fibromyalgia trial but recruitment has now closed. If you would like to register for future Fibromyalgia studies please contact MAC.
You can find out more about the Fibromyalgia trial here
Psoriasis is an immune condition which causes raised patches of inflamed skin.
Photo from Psoriasis Association
It's a common condition which can affect up to 3% of the population. Psoriatic Arthritis is a form of arthritis associated with the condition.
MAC Clinical Research is currently running a clinical trial looking in to a potential new treatment for PSORIASIS. To register please visit: researchforyou.co.uk or contact our recruitment team on 0800 6335507 (and please mention this website!)
To find out more about Psoriasis, visit Psoriasis Association's website here
MAC Research has partnered with Starley Racing for 2016 to put their expertise in science into cycling, and improve rider’s performance on and off their bikes, with the aim that research associated with the professional cycling team will help hundreds of ordinary people living with osteoarthritis to get control of their pain and get on with their lives.
MAC is passionate about driving clinical excellence forward to promote health, and has been inspired by the British Cycling ‘marginal gains’ philosophy and the success it has created in professional cycling. Since the success of the London 2012 Olympics, thousands of recreational cyclists have taken to the road to enjoy the health benefits of this non-impact sport.
MAC has focused its attention in 2016 on developing medicines that will contribute to the management of chronic pain in hip and knee osteoarthritis. They are also establishing specialist knee arthritis clinics, offering specialist assessment and physiotherapy services in each one of its research centres, to further promote regular cycling which is often prescribed as an important strengthening treatment to help with the patient’s pain.
MAC says: "In supporting the team this year we hope to reach out to all cyclists who perhaps have already been diagnosed with joint arthritis and are not sure what to do next to get their pain under control. MAC have already seen in the clinic that non-body weight exercise, which is a large part of the patients treatment is beginning to produce some dramatic results.
"In the same way that MAC is using science to improve Starley Racing's rider’s performance, our research and development department has built a unique approach to managing the patient with osteoarthritis through a marginal gains philosophy, where all the causative factors that contribute to the patients pain are addressed at once.
"With access to the team, we can look at the individuals that are really putting big pressures and high demand on their body, looking at recovery, rehab and performance gains benefiting our research further."
MAC met with the Starley Racing team last week in its first performance camp of the season and fed back the results of each rider’s performance medical. Putting in place the first part of the teams matrix of testing, helping them develop as individuals towards a collective goal.
The thorough screening process on the day included six stations which ranged from analysing the riders mechanics on the bike, Dexa scanning their body to measure their body composition and maximally testing their strength to record any asymmetry from their left to right leg.
As a result of the medical screening by MACs team, each rider was given an individualised performance plan and the process will be repeated throughout the season for comparison.
Doug Jones who has worked as a physiotherapist in professional sport for over ten years and Heads MACs sports medicine group will deliver this seasons High Performance Program for Starley. MAC has also secured the services of some of the best practitioners from British Cycling and the England Institute of Sport under Doug’s team and together they aim to uncover any potential factor that could contribute to the rider suffering with an injury as their training and racing volume begins to increase.
Nick Fountain – Starley Racing’sTeam Manager said: "We believe looking after the riders welfare, health and personal performance will not only help them each to develop, but also give the team something very unique at this level, normally associated with the likes of big budget teams such as team Sky.
"Having MAC and Doug Jones' team on board will give us a great point of difference, investing in our riders and the team’s future. Giving the riders access to this level of support should allow them to develop as individuals towards their personal goals, along with the teams continued growth through sponsorship.'
MAC will follow the rider’s highs and lows throughout the year and share news and events. MAC hopes that the research associated with the professional cycling team will help hundreds of ordinary people living with osteoarthritis to get control of their pain and get on with their lives.
Clinical research helps to improve quality of life for many people around the world, by enabling the development of new and improved treatments. Without research there would be no new medications! #ClinicalResearch #ClinicalTrials #MACClinicalResearch #DementiaResearch #AlzheimersResearch #Dementia #Alzheimers #Memory #Health #HealthyVolunteers #Arthritis #Osteoarthritis #ArthritisResearch #Manchester #Leeds #Blackpool #Liverpool #Barnsley #Cannock
JOB OPPORTUNITY Exciting opportunities have arisen for PHARMACY TECHNICIANS to join our Leeds team in our licensed GMP Pharmacy suite. MAC invites applications from highly motivated candidates, with a desire to fulfil their full potential. You will be working with an organisation that sees you as an investment and is keen for you to achieve your career aspirations. Experience for these roles is essential but further training will be provided. We offer a competitive and negotiable salary. Closing date for applications: 28th February 2017. To find out more, or to apply, visit: https://www.macplc.com/pharmacy-technician-gmpsuite #Pharmacy #PharmacyTechnician #Pharmacist #PharmacySuite #MACClinicalResearch #ClinicalResearch #ClinicalTrials
Over 850,000 people in the UK are living with dementia. But what IS dementia? The Alzheimer's Society have released a series of short films explaining what the condition is. You can watch them here: http://ow.ly/X9Z1308SKzi https://www.facebook.com/alzheimerssocietyuk/videos/10154911797654647/ #Dementia #DementiaResearch #JoinDementiaResearch #Alzheimers #AlzheimersResearch #AlzheimersSociety #Memory #ClinicalResearch #ClinicalTrials
Dementia isn’t a natural part of ageing. It’s caused by different diseases that affect the brain, including Alzheimer’s disease. It’s a progressive condition, meaning that symptoms gradually get worse. ‘What is dementia?’ is part of our series of films on dementia and the brain. Watch the others now at http://ow.ly/X9Z1308SKzi
We're currently running clinical trials looking into potential treatments for osteoarthritis and dementia. We're also conducting a trial for healthy volunteers. Want to find out more? Visit www.researchforyou.co.uk #MACClinicalResearch #ClinicalResearch #ClinicalTrials #HealthyVolunteers #Healthy #Volunteer #Health #Dementia #DementiaResearch #JoinDementiaResearch #Alzheimers #AlzheimersResearch #Memory #Arthritis #ArthritisResearch #Osteoarthritis #Pain #ChronicPain
Are you a QUALIFIED NURSE looking to change career direction or take on a new role? If so, the Early Phase Unit at MAC Clinical Research have an exciting opportunity for YOU! Based at Citylabs 1.0 within the Manchester Royal Infirmary site, the Early Phase Unit is a new and exciting entity here at MAC. Working in a small, close-knit team, the staff are enthusiastic and passionate about clinical research. Think you’d fit in well with our team? The Early Phase Unit is looking for full-time nursing staff to join its accredited clinical trials unit, researching and assisting in the development of new pharmaceutical medicines across a wide range of therapeutic areas. We can offer a competitive salary, immediate start, full training (clinical research experience not essential), professional development and the chance to work in a great team environment. Shift work will be required (early, late, weekend and nights) but is allocated on a rota basis. For further details or to apply, please visit: https://www.macplc.com/prospective-job-application #ClinicalResearch #ClinicalTrials #MACClinicalResearch #ResearchNurse #Nurse #QualifiedNurse #Opportunity #JobOpportunity #Manchester #GreaterManchester
On Friday 27th January, our Cannock team held a Dementia Research Awareness Day at The Northfield Centre, Stafford. Want to learn more about our current clinical research looking into a potential new treatment for dementia? Visit: researchforyou.co.uk Thanks to the following organisations for helping to make the event a success: Approach Staffordshire Age UK South Staffordshire CASS The Carers Association Positive Steps Medequip The Carers Hub Crispin Court Care Home Inspirations Health and Beauty & Make Your Day Amazing #Dementia #DementiaResearch #JoinDementiaResearch #DementiaAwareness #DementiaFriend #Alzheimers #AlzheimersResearch #Memory #MemoryAssessment #Stafford #Staffordshire #MACClinicalResearch #ClinicalResearch #ClinicalTrials
Struggling to sleep? Check out these tips for a better night's kip! http://www.greenhealingnow.com/2015/04/28/4-ways-to-get-your-natural-circadian-rhythm-back/?platform=hootsuite #sleep #tired #insomnia #yawn #sleepy #bedtime #nap #kip #awake #circadianrhythms
One of the major causes of insomnia is a disruption in the circadian rhythm. The body has a natural circadian rhythm which is dictated by the production...
Spent the morning with BBC Apprentice 2016's Rebecca Jeffery, who provided MAC with some top marketing tips! Thanks Rebecca! #Marketing #PR #BBC #TheApprentice #MACClinicalResearch #ClinicalTrials #ClinicalResearch #ArthritisResearch #Osteoarthritis #Arthritis #Dementia #DementiaResearch #JoinDementiaResearch #Alzheimers #AlzheimersResearch #Memory #HealthyVolunteers
A potential new treatment for dementia is being developed by Defying Dementia at Lancaster University. The treatment will go through its first phase of clinical research here at MAC! #ClinicalResearch #ClinicalTrials #MACClinicalResearch #Dementia #DementiaResearch #JoinDementiaResearch #Alzheimers #AlzheimersResearch #Memory #DefyingDementia #LancasterUniversity #Lancaster #Lancashire
Dr Peter Dewland, Senior Director of Early Phase Research here at MAC & our 'pain expert' Dr John Connell, gave a talk about our research into pain at CityLabs, Manchester this morning. We use a variety of methods for testing pain both in healthy volunteers and in patients with chronic pain conditions, some of which were demonstrated at this morning's event! Thanks Manchester Science Partnerships for the photos! #Pain #ChronicPain #PainTesting #PainResearch #ClinicalResearch #ClinicalTrials #MACClinicalResearch #CityLabs #Manchester
Check out our new cardiac arrest fact sheet & find out how you can use simple skills to save lives:… twitter.com/i/web/status/8…